Published in J Virol on February 01, 1983
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol (2002) 5.82
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol (1984) 4.98
Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol (1998) 4.71
Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol (1988) 4.64
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 4.57
Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol (1986) 4.33
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A (1984) 3.92
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci U S A (1994) 3.59
Factors that bind to adeno-associated virus terminal repeats. J Virol (1989) 3.56
Parvovirus replication. Microbiol Rev (1990) 3.37
Cloning and characterization of adeno-associated virus type 5. J Virol (1999) 3.36
Negative and positive regulation in trans of gene expression from adeno-associated virus vectors in mammalian cells by a viral rep gene product. Mol Cell Biol (1986) 3.34
Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31
Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev (2008) 3.30
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol (2003) 3.25
Identification of the trans-acting Rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. J Virol (1986) 3.09
Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol (1997) 2.91
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol (1987) 2.85
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84
Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol (1987) 2.74
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Complete nucleotide sequence and genome organization of bovine parvovirus. J Virol (1986) 2.69
Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome. J Virol (1990) 2.62
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J Virol (1994) 2.52
The fecal viral flora of wild rodents. PLoS Pathog (2011) 2.51
DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol (1994) 2.50
A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol (1984) 2.36
Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J Virol (1994) 2.32
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J Virol (1996) 2.32
Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein. J Virol (1991) 2.31
Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J Virol (1993) 2.22
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol Cell Biol (1985) 2.21
In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09
Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol (1997) 2.06
Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. J Virol (2005) 2.05
Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein. J Virol (1988) 2.03
Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol (2001) 2.03
Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat. J Virol (1994) 1.98
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J Virol (1994) 1.98
Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol (1989) 1.96
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A (1997) 1.91
Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol (1988) 1.89
The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol (1997) 1.89
Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins. J Virol (1995) 1.86
Complete DNA sequence of the rat cytomegalovirus genome. J Virol (2000) 1.85
Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84
A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini. J Virol (2005) 1.79
A viral assembly factor promotes AAV2 capsid formation in the nucleolus. Proc Natl Acad Sci U S A (2010) 1.78
Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro. J Virol (1992) 1.74
A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities. J Virol (1995) 1.72
Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol (1997) 1.72
Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J Virol (1995) 1.71
Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV. J Virol (1988) 1.70
DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol Ther (2008) 1.70
Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol (2004) 1.67
Replication of adeno-associated virus in cells irradiated with UV light at 254 nm. J Virol (1989) 1.67
The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny single-stranded DNA but is required for infectivity. J Virol (1993) 1.67
Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition. J Virol (1992) 1.64
Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses. J Virol (2002) 1.64
The Rep78 gene product of adeno-associated virus (AAV) self-associates to form a hexameric complex in the presence of AAV ori sequences. J Virol (1997) 1.63
Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol (1995) 1.63
The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity. J Virol (1998) 1.61
Detailed transcription map of Aleutian mink disease parvovirus. J Virol (1988) 1.58
Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther (2009) 1.57
Mutation of a consensus purine nucleotide binding site in the adeno-associated virus rep gene generates a dominant negative phenotype for DNA replication. J Virol (1990) 1.56
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes. J Virol (1999) 1.55
Generation and characterization of chimeric recombinant AAV vectors. Mol Ther (2003) 1.54
Adeno-associated virus rep protein synthesis during productive infection. J Virol (1989) 1.54
Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep (2001) 1.53
Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res (2007) 1.50
Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol (1998) 1.50
Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels. J Virol (1994) 1.48
Cloning and characterization of a bovine adeno-associated virus. J Virol (2004) 1.46
Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities. J Virol (1999) 1.45
Requirement for either early region 1a or early region 1b adenovirus gene products in the helper effect for adeno-associated virus. J Virol (1984) 1.45
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42
Can ACG serve as an initiation codon for protein synthesis in eucaryotic cells? Mol Cell Biol (1985) 1.41
Cellular transcription factor binds to adenovirus early region promoters and to a cyclic AMP response element. J Virol (1988) 1.37
Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. J Virol (2000) 1.37
In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of rep. J Virol (1992) 1.36
Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J Virol (1997) 1.35
Mutational analysis of the adeno-associated virus rep gene. J Virol (1992) 1.35
The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. J Virol (1997) 1.34
Structural proteins of adenovirus-associated virus: subspecies and their relatedness. J Virol (1983) 1.34
The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation. J Virol (1997) 1.34
A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19. Proc Natl Acad Sci U S A (2002) 1.31
Characterization of tissue tropism determinants of adeno-associated virus type 1. J Virol (2003) 1.29
Detection of adeno-associated virus type 2 sequences in the human genital tract. J Clin Microbiol (1997) 1.29
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol (1998) 1.28
Molecular engineering of viral gene delivery vehicles. Annu Rev Biomed Eng (2008) 1.28
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Transposable elements. Cell (1980) 10.84
ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science (1965) 9.77
Enzymatic synthesis of deoxyribonucleic acid. XI. Further studies on nearest neighbor base sequences in deoxyribonucleic acids. J Biol Chem (1962) 7.80
Definition of a novel promoter for the major adenovirus-associated virus mRNA. Cell (1980) 7.42
Simian virus 40 early mRNA's. I. Genomic localization of 3' and 5' termini and two major splices in mRNA from transformed and lytically infected cells. J Virol (1979) 5.93
Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol (1980) 5.09
Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73
Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62
Palindromic base sequences and replication of eukaryote chromosome ends. Nature (1974) 4.33
Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J Virol (1980) 3.52
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Spliced adenovirus-associated virus RNA. Proc Natl Acad Sci U S A (1979) 2.99
Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science (1969) 2.76
Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol (1982) 2.75
DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res (1982) 2.50
Transcripts of the adeno-associated virus genome: mapping of the major RNAs. J Virol (1980) 2.42
Adeno-associated viruses. Adv Virus Res (1979) 2.35
Arrangement of nucleotide sequences in adeno-associated virus DNA. J Mol Biol (1973) 2.30
Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol (1972) 2.15
Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein. Proc Natl Acad Sci U S A (1981) 2.08
Adenovirus-associated virus multiplication. VI. Base compostion of the deoxyribonucleic acid strand species and strand-specific in vivo transcription. J Virol (1971) 2.05
Defective-interfering particles of the human parvovirus adeno-associated virus. Virology (1979) 2.05
Adenovirus-associated virus multiplication. IX. Extent of transcription of the viral genome in vivo. J Virol (1972) 1.87
Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology (1977) 1.75
The role of herpesviruses in adenovirus-associated virus replication in vitro. Virology (1970) 1.70
Adenovirus-associated virus multiplication. 8. Analysis of in vivo transcription induced by complete or partial helper viruses. J Virol (1972) 1.65
Adeno-associated virus DNA replication. Cold Spring Harb Symp Quant Biol (1979) 1.65
Transcripts of the adenovirus-associated virus genome: multiple polyadenylated RNAs including a potential primary transcript. J Virol (1980) 1.63
Study of the fine structure of adeno-associated virus DNA with bacterial restriction endonucleases. J Virol (1975) 1.60
Genome localization of adeno-associated virus RNA. J Virol (1976) 1.36
Complete nucleotide sequence of the polymerase 3 gene of human influenza virus A/WSN/33. J Virol (1982) 1.35
Adenovirus early region 1b gene function required for rescue of latent adeno-associated virus. Virology (1980) 1.28
Intracellular distribution and polyadenylate content of adeno-associated virus RNA sequences. Virology (1976) 1.23
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89
Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med (1999) 5.50
Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell (1983) 5.27
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol (1980) 5.09
Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost (2006) 4.58
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J (1992) 4.36
Characteristics and taxonomy of Parvoviridae. Intervirology (1985) 3.70
Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67
Delta-F508 cystic fibrosis mutation is not linked to intussusception: implications for rotavirus vaccine. J Paediatr Child Health (2003) 3.59
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA. J Virol (1980) 3.52
Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India (2007) 3.52
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics (1991) 3.47
Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA. J Mol Biol (1974) 3.20
Origin and termination of adeno-associated virus DNA replication. Virology (1977) 3.14
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes. Mol Cell Biol (1987) 2.85
Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology (1975) 2.77
Mapping of the 5' termini of two adeno-associated virus 2 RNAs in the left half of the genome. J Virol (1982) 2.75
The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci U S A (1996) 2.74
Adeno-associated viruses: an update. Adv Virus Res (1987) 2.71
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. J Virol (1989) 2.60
Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2005) 2.45
Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology (1989) 2.43
Natural occurrence of cross-linked vaccinia virus deoxyribonucleic acid. J Virol (1970) 2.41
Adeno-associated viruses. Adv Virus Res (1979) 2.35
Arrangement of nucleotide sequences in adeno-associated virus DNA. J Mol Biol (1973) 2.30
Letter: Visualization of the inverted terminal repetition in adeno-associated virus DNA. J Mol Biol (1974) 2.25
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc Natl Acad Sci U S A (1994) 2.25
Convergent sensing pathways mediate response to two extracellular competence factors in Bacillus subtilis. Genes Dev (1995) 2.24
Separation of two types of adeno-associated virus particles containing complementary polynucleotide chains. J Virol (1972) 2.15
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol (1986) 2.12
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
X chromosome map at 75-kb STS resolution, revealing extremes of recombination and GC content. Genome Res (1997) 2.06
Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol (2001) 2.03
Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol (1995) 2.02
Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J Virol (2000) 2.01
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Should ice be used in the treatment of acute haemarthrosis in haemophilia? Haemophilia (2013) 1.92
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci U S A (1997) 1.91
Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology (1988) 1.88
Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience. Leukemia (2004) 1.76
Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology (1977) 1.75
Adeno-associated virus DNA replication: nonunit-length molecules. Virology (1979) 1.74
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer (2001) 1.73
Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther (2001) 1.71
Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2006) 1.70
Cytokines in human milk. Res Commun Mol Pathol Pharmacol (1996) 1.70
Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak. Transpl Infect Dis (2011) 1.67
Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology (1981) 1.65
Adeno-associated virus DNA replication. Cold Spring Harb Symp Quant Biol (1979) 1.65
The remaining stocks of smallpox virus should be destroyed. Science (1993) 1.62
Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost (2000) 1.62
In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. J Mol Biol (1991) 1.61
Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene (1997) 1.60
Study of the fine structure of adeno-associated virus DNA with bacterial restriction endonucleases. J Virol (1975) 1.60
In vitro replication of adeno-associated virus DNA. Proc Natl Acad Sci U S A (1992) 1.60
Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol (2001) 1.58
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein. J Virol (1994) 1.56
A pilot study on the role of T-tube in typhoid ileal perforation in children. World J Surg (2008) 1.51
Adeno-associated virus type 2-mediated gene transfer: role of epidermal growth factor receptor protein tyrosine kinase in transgene expression. J Virol (1998) 1.50
Vanadate inhibits blue light-stimulated swelling of vicia guard cell protoplasts. Plant Physiol (1992) 1.45
Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther (1997) 1.45
Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc Natl Acad Sci U S A (2001) 1.45
The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42
One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol (2009) 1.39
Impact of delay in inguinal lymph node dissection in patients with carcinoma of penis. Indian J Cancer (2009) 1.38
Infection of purified nuclei by adeno-associated virus 2. Mol Ther (2001) 1.37
Genome localization of adeno-associated virus RNA. J Virol (1976) 1.36
Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia (2006) 1.36
Parvovirus gene regulation. J Gen Virol (1987) 1.35
Adenovirus early region 1b gene function required for rescue of latent adeno-associated virus. Virology (1980) 1.28
The significance of blood flow in cutaneous malignant melanoma demonstrated by Doppler flowmetry. Eur J Surg Oncol (1986) 1.27
Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol (1997) 1.27
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med (1994) 1.26
Allogeneic bone marrow transplantation in the developing world: experience from a center in India. Bone Marrow Transplant (2001) 1.25
Interactions between the termini of adeno-associated virus DNA. J Mol Biol (1989) 1.25
A study of reported factor VIII use around the world. Haemophilia (2009) 1.24
Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells. J Virol (1997) 1.23
Phytotoxic and antimicrobial constituents of Argyreia speciosa and Oenothera biennis. J Ethnopharmacol (1999) 1.22
Yeast artificial chromosome-based genome mapping: some lessons from Xq24-q28. Genomics (1991) 1.21
Stones associated renal pelvic malignancies. Indian J Cancer (2004) 1.19
Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol (1997) 1.18
In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J Virol (1996) 1.18
Multiple effects of chromate on the photosynthetic apparatus of Spirodela polyrhiza as probed by OJIP chlorophyll a fluorescence measurements. Environ Pollut (2001) 1.18
Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol (2001) 1.17
Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus. Proc Natl Acad Sci U S A (1989) 1.17
Rescue and replication signals of the adeno-associated virus 2 genome. J Mol Biol (1995) 1.17
Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol (1993) 1.16
Efficient uptake of Yersinia pseudotuberculosis via integrin receptors involves a Rac1-Arp 2/3 pathway that bypasses N-WASP function. Mol Microbiol (2001) 1.16